查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1390600

2023-2028年按產品類型、給藥途徑、疾病、應用和地區分類的疫苗佐劑市場報告

Vaccine Adjuvants Market Report by Product Type, Route of Administration, Diseases, Application, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年全球疫苗佐劑市場規模達到8.84億美元。展望未來， IMARC Group預計到2028年市場規模將達到18.12億美元，2022-2028年複合年成長率（CAGR）為12.71%。人們日益關注開發有效的疫苗、大眾傳染病的流行以及人們對疫苗接種在預防疾病和改善公共衛生方面重要性的認知不斷提高，是推動市場的一些主要因素。

疫苗佐劑是一種添加到疫苗中以增強疫苗引發的免疫反應的物質或化合物。它們經過廣泛的測試和監管監督，以確保它們不會在注射部位造成除了輕微和短暫反應之外的極端影響。它們與疫苗中的抗原相容，不應干擾其活性。它們可作為免疫增強劑，確保更強大和持久的免疫反應。它們顯著提高身體識別和記憶抗原的能力，從而產生更強大和持久的免疫反應。

目前，對疫苗佐劑的需求不斷增加，因為它們允許使用較小的疫苗劑量，這在疫苗生產推動市場成長的情況下至關重要。除此之外，疫苗佐劑的日益普及，因為它們能夠在大流行期間快速開發疫苗，並允許在不影響功效的情況下使用更少量的抗原，這也促進了市場的成長。此外，各國政府機構也擴大進行疫苗接種活動以消除各種疾病，這提供了良好的市場前景。除此之外，生物技術、免疫學和基因組學的不斷進步正在支持市場的成長。此外，人們越來越認知到疫苗接種在預防疾病和改善公共衛生方面的重要性，這也促進了市場的成長。

疫苗佐劑市場趨勢/促進因素：

越來越重視開發有效的疫苗

目前對開發有效疫苗的日益關注正在對疫苗佐劑市場的成長產生積極影響。除此之外，疫苗佐劑在改善疫苗產生的免疫反應方面發揮著至關重要的作用，從而確保更好地預防傳染病。隨著製藥公司和研究機構不斷投資開發新出現疾病的新型疫苗，對先進高效佐劑的需求不斷增加。此外，正在進行的全球疫苗接種運動旨在消除由各種病毒引起的多種傳染病，這凸顯了疫苗佐劑在加速生產安全有效疫苗方面的重要性。旨在創造具有更高免疫原性的疫苗的持續研發（R＆D）活動正在將佐劑的需求推向新的高度。

佐劑技術不斷進步

目前，佐劑技術的不斷進步正在推動疫苗佐劑市場的成長。隨著持續的研究和開發 (R&D) 措施不斷增強疫苗配方中使用的佐劑的能力和功效，該行業正在經歷顯著的轉變。研究人員和科學家目前正在開發和微調創新佐劑技術，這些技術能夠顯著增強疫苗引起的免疫反應。這些進步正在應用於針對各種傳染病的疫苗配方中。此外，佐劑技術的進步正在促進更高的疫苗開發效率和有效性。這意味著對新出現的感染威脅（例如新型病原體和不斷進化的病毒株）做出更快速的反應。

群眾傳染病流行率上升

目前，傳染病在大眾中日益流行，對疫苗佐劑市場的成長產生了積極影響。這種現象主要歸因於人們對疫苗接種作為預防各種傳染病的重要性的認知的提高。由於這些疾病持續對公共衛生構成重大威脅，對有效疫苗的需求不斷成長。此外，加快開發疫苗的迫切性導致佐劑研發（R＆D）投資的增加。對疫苗佐劑的高度關注有利於當前市場，並為未來的成長機會鋪平道路。

疫苗佐劑行業區隔：

IMARC Group提供了全球疫苗佐劑市場報告各細分市場主要趨勢的分析，以及 2023-2028 年全球、區域和國家層面的預測。我們的報告根據產品類型、給藥途徑、疾病和應用對市場進行了分類。

按產品類型分類：

佐劑乳劑

病原體成分

顆粒佐劑

組合佐劑

其他

助劑乳液主導市場

該報告根據產品類型對市場進行了詳細的細分和分析。這包括佐劑乳液、病原體成分、顆粒佐劑、組合佐劑等。根據該報告，佐劑乳液代表了最大的部分。

佐劑乳液是用於各個領域（包括疫苗）的專門製劑，用於增強免疫系統。它們可以幫助穩定抗原，否則這些抗原可能會分解或被迅速從體內清除。佐劑乳劑可以使疫苗抗原更具免疫原性，這意味著它們能夠更好地刺激免疫反應。當處理本身免疫原性較低的抗原時，這一點尤其重要。此外，疫苗中使用的佐劑乳液在獲得監管部門批准之前要經過嚴格的安全性和有效性測試。此外，使用佐劑乳劑可以產生更有效的疫苗，提供更好的目標疾病的保護。這在需要強烈且持續的免疫反應的情況下尤其重要。

依給藥途徑分類：

口服

肌肉注射

鼻內

皮下

皮內

其他

肌肉注射佔市場最大佔有率

報告還根據給藥途徑對市場進行了詳細的細分和分析。這包括口服、肌肉內、鼻內、皮下、皮內等。報告稱，肌肉注射佔據了最大的市場佔有率。

肌肉注射疫苗具有許多好處，有助於其在免疫計劃中的廣泛使用。由於肌肉中的血液供應增強，它促進了快速而強大的免疫反應，確保疫苗抗原有效吸收到血液中。它還保持疫苗的穩定性和完整性，保護脆弱的抗原並實現可靠的疫苗傳遞。此外，它用途廣泛，適用於多種疫苗，包括去活化疫苗、減毒活疫苗和基於蛋白質的製劑，使其成為各種免疫接種的首選途徑。這種適應性延伸到從嬰兒到老年人的所有年齡段，促進了全面的疫苗接種計劃。

依疾病分類：

癌症

傳染性疾病

其他

傳染病佔市場最大佔有率

報告還根據疾病對市場進行了詳細的細分和分析。這包括癌症、傳染病等。報告稱，傳染病佔據最大的市場佔有率。

疫苗佐劑在開發有效的傳染病疫苗中發揮著至關重要的作用。它們刺激並增強對疫苗中抗原的免疫反應。這意味著可以使用較少的抗原，從而降低疫苗生產成本和潛在的副作用。疫苗佐劑可以幫助延長免疫反應，確保人體在較長時間內持續產生抗體和記憶細胞。這可以帶來針對傳染源的更持久的保護。此外，可以客製化疫苗佐劑以引發特定類型的免疫反應。此外，它們可以透過增強老年人的免疫反應來幫助克服免疫老化。

按應用分類：

研究

商業的

研究在市場上佔有最大佔有率

報告還提供了基於應用程式的詳細市場細分和分析。這包括研究和商業。報告顯示，研究佔據了最大的市場佔有率。

疫苗佐劑是疫苗研究領域的關鍵組成部分，在提高疫苗的有效性和安全性方面發揮關鍵作用。這些物質被添加到疫苗配方中以增強免疫反應，最終更好地預防傳染病。佐劑在開發使用傳統疫苗方法難以標靶的病原體的疫苗時特別有價值，例如具有快速突變表面蛋白或弱免疫原性成分的病毒。它們是疫苗研究中不可或缺的工具，可增強免疫反應、減少抗原劑量並微調免疫系統反應的特定性。此外，科學家正在研究新型佐劑配方和遞送方法，以最大限度地提高其有效性，同時最大限度地減少潛在的副作用。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美表現出明顯的主導地位，佔據最大的疫苗佐劑市場佔有率

市場研究報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美佔據最大的市場佔有率。

由於醫療保健行業不斷進步，為患者提供品質治療，北美佔據了最大的市場佔有率。除此之外，對用於治療罕見疾病的各種新型疫苗、療法和藥物的開發的日益關注正在推動市場的成長。除此之外，生物技術和免疫學領域的不斷進步，使得能夠開發出安全性更高、功效更強的佐劑，正在支持市場的成長。

由於新型病毒引起的多種傳染病的盛行率不斷上升，預計亞太地區在這一領域的規模將進一步擴大。此外，擴大進行公眾意識活動和教育工作來宣傳疫苗接種的好處，這也促進了市場的成長。

競爭格局：

主要市場參與者正在透過探索新的佐劑配方、遞送機制以及與疫苗的組合來開發創新且更有效的佐劑，以提高其功效和安全性。他們還與疫苗製造商、生物技術公司和研究機構建立策略夥伴關係和合作，以共享專業知識和資源並進入新市場。頂尖公司正在透過開發可用於各種類型疫苗（包括傳染病、癌症和自體免疫疾病疫苗）的佐劑來擴大其產品組合。他們也致力於確保其佐劑符合必要的監管要求和安全標準。領先公司正在擴大在新興市場的業務，這些市場對疫苗和疫苗佐劑的需求不斷成長。他們還建立製造設施、分銷網路以及與當地組織的合作夥伴關係。

該報告對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。市場上的一些主要參與者包括：

輔助科技公司

佐瓦蒂斯

阿吉努斯公司

布倫塔格SE

凱姆貿易物流公司

中超有限公司

禾大國際股份有限公司

英維健

諾瓦瓦克斯公司

奧茲生物科學公司

維羅美泰克公司

最近的發展：

2022 年 1 月，Adjuvance Tecchnologies Inc. 宣布美國專利商標局 (USPTO) 授予一項涉及半合成皂苷佐劑的美國專利，該佐劑表現出改進的佐劑活性和降低的毒性。

2021 年 9 月，Agenus Inc. 宣布成立子公司 SaponiQx，該子公司將推動新型佐劑發現和疫苗生產的創新。

2023 年 6 月，Novavax Inc. 宣布批准國家藥品監管局 (ANRP) 批准 R21/Matrix-M (TM) 瘧疾疫苗，其中含有其基於皂苷的佐劑 Matrix-M。布吉納法索用於兒童。

本報告回答的關鍵問題

  • 2022年全球疫苗佐劑市場規模是多少
  • 2023-2028年全球疫苗佐劑市場預計成長率是多少
  • 推動全球疫苗佐劑市場的關鍵因素是什麼
  • COVID-19對全球疫苗佐劑市場有何影響
  • 根據產品類型，全球疫苗佐劑市場的細分如何
  • 根據給藥途徑，全球疫苗佐劑市場的細分如何
  • 基於疾病的全球疫苗佐劑市場的細分是什麼
  • 基於應用的全球疫苗佐劑市場區隔如何
  • 全球疫苗佐劑市場的重點區域有哪些
  • 10. 全球疫苗佐劑市場的主要參與者/公司有哪些？

本報告回答的關鍵問題

  • 2022年全球疫苗佐劑市場規模有多大？
  • 2023-2028年全球疫苗佐劑市場的預期成長率是多少？
  • 推動全球疫苗佐劑市場的關鍵因素是什麼？
  • COVID-19對全球疫苗佐劑市場有何影響？
  • 根據產品類型，全球疫苗佐劑市場的細分如何？
  • 根據給藥途徑，全球疫苗佐劑市場的細分如何？
  • 全球疫苗佐劑市場根據疾病的分類是怎樣的？
  • 根據應用，全球疫苗佐劑市場的細分如何？
  • 全球疫苗佐劑市場的重點區域有哪些？
  • 全球疫苗佐劑市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球疫苗佐劑市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：依產品類型分類的市場區隔

  • 佐劑乳劑
    • 市場走向
    • 市場預測
  • 病原體成分
    • 市場走向
    • 市場預測
  • 顆粒佐劑
    • 市場走向
    • 市場預測
  • 組合佐劑
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：按管理途徑分類的市場

  • 口服
    • 市場走向
    • 市場預測
  • 肌肉注射
    • 市場走向
    • 市場預測
  • 鼻內
    • 市場走向
    • 市場預測
  • 皮下
    • 市場走向
    • 市場預測
  • 皮內
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：疾病導致的市場分裂

  • 癌症
    • 市場走向
    • 市場預測
  • 傳染性疾病
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：按應用分類的市場區隔

  • 研究
    • 市場走向
    • 市場預測
  • 商業的
    • 市場走向
    • 市場預測

第 10 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Adjuvance Tecchnologies Inc.
    • Adjuvatis
    • Agenus Inc.
    • Brenntag SE
    • Chemtrade Logistics Inc.
    • CSL Limited
    • Croda International Plc
    • Invivogen
    • Novavax Inc.
    • OZ Biosciences
    • Virometix AG
Product Code: SR112023A4385

Abstract

The global vaccine adjuvants market size reached US$ 884 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,812 Million by 2028, exhibiting a growth rate (CAGR) of 12.71% during 2022-2028. The growing focus on developing effective vaccines, increasing prevalence of infectious diseases among the masses, and rising awareness about the importance of vaccination in preventing diseases and improving public health are some of the major factors propelling the market.

Vaccine adjuvants are substances or compounds added to vaccines to enhance the immune response triggered by the vaccine. They undergo extensive testing and regulatory oversight to ensure that they do not cause extreme effects beyond mild and transient reactions at the injection site. They are compatible with the antigens in the vaccine and should not interfere with their activity. They serve as immunological boosters, ensuring a more robust and long-lasting immune response. They significantly improve the ability of the body to recognize and remember antigens, resulting in a more robust and durable immune response.

At present, the increasing demand for vaccine adjuvants as they allow for the use of smaller vaccine doses, which can be critical in situations where vaccine production is impelling the growth of the market. Besides this, the rising popularity of vaccine adjuvants, as they enable the rapid development of vaccines during pandemics and allow smaller quantities of antigens to be used without compromising efficacy, is contributing to the growth of the market. In addition, the growing conduction of vaccination drives by governing agencies of various countries to eradicate various diseases is offering a favorable market outlook. Apart from this, increasing advancements in biotechnology, immunology, and genomics are supporting the growth of the market. Additionally, the rising awareness about the importance of vaccination in preventing diseases and improving public health is bolstering the growth of the market.

Vaccine Adjuvants Market Trends/Drivers:

Growing focus on developing effective vaccines

The growing focus on developing effective vaccines is currently exerting a positive influence on the growth of the vaccine adjuvants market. Besides this, vaccine adjuvants play a crucial role in improving the immune response generated by vaccines, thereby ensuring better protection against infectious diseases. As pharmaceutical companies and research institutions continue to invest in the development of novel vaccines for emerging diseases, the need for advanced and efficient adjuvants is rising. Furthermore, the ongoing global vaccination campaigns for eradicating numerous infectious diseases caused by various viruses are underscoring the significance of vaccine adjuvants in expediting the production of safe and effective vaccines. The continuous research and development (R&D) activities aimed at creating vaccines with higher immunogenicity are propelling the demand for adjuvants to new heights.

Rising advancements in adjuvant technology

At present, rising advancements in adjuvant technology are bolstering the growth of the vaccine adjuvants market. This sector is experiencing a remarkable transformation as ongoing research and development (R&D) initiatives are continually enhancing the capabilities and efficacy of adjuvants used in vaccine formulations. Researchers and scientists are currently developing and fine-tuning innovative adjuvant technologies that are capable of significantly augmenting the immune response elicited by vaccines. These advancements are being implemented in vaccine formulations that target various infectious diseases. Furthermore, the advancements in adjuvant technology are fostering greater vaccine development efficiency and effectiveness. This translates into a more rapid response to emerging infectious threats, such as novel pathogens and evolving viral strains.

Increasing prevalence of infectious diseases among the masses

The increasing prevalence of infectious ailments among the masses is currently positively influencing the growth of the vaccine adjuvants market. This phenomenon is primarily attributed to the heightened awareness of the importance of vaccination as a preventive measure against various infectious diseases. As these diseases continue to pose a significant public health threat, there is a growing demand for effective vaccines. Additionally, the urgency to develop vaccines at an accelerated pace is leading to an increase in investments in adjuvant research and development (R&D). This heightened focus on vaccine adjuvants is benefiting the current market and paving the way for future growth opportunities.

Vaccine Adjuvants Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global vaccine adjuvants market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product type, route of administration, diseases and application.

Breakup by Product Type:

Adjuvant Emulsions

Pathogen Components

Particulate Adjuvants

Combination Adjuvants

Others

Adjuvant emulsions dominate the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes adjuvant emulsions, pathogen components, particulate adjuvants, combination adjuvants, and others. According to the report, adjuvant emulsions represented the largest segment.

Adjuvant emulsions are specialized formulations used in various fields, including vaccines, to enhance the immune system. They can help stabilize antigens that may otherwise degrade or be rapidly cleared from the body. Adjuvant emulsions can make vaccine antigens more immunogenic, meaning they are better at stimulating an immune response. This is particularly important when dealing with antigens that are less immunogenic on their own. Moreover, adjuvant emulsions used in vaccines go through rigorous testing for safety and efficacy before receiving regulatory approval. Furthermore, the use of adjuvant emulsions can result in a more effective vaccine, providing better protection against the targeted disease. This is particularly important in cases where a strong and sustained immune response is needed.

Breakup by Route of Administration:

Oral

Intramuscular

Intranasal

Subcutaneous

Intradermal

Others

Intramuscular holds the largest share in the market

A detailed breakup and analysis of the market based on the route of administration has also been provided in the report. This includes oral, intramuscular, intranasal, subcutaneous, intradermal, and others. According to the report, intramuscular accounted for the largest market share.

Intramuscular vaccine administration offers numerous benefits that contribute to its widespread use in immunization programs. It facilitates a rapid and robust immune response due to the enhanced blood supply in the muscles, ensuring efficient uptake of vaccine antigens into the bloodstream. It also maintains the stability and integrity of vaccines, protecting fragile antigens and enabling reliable vaccine delivery. Furthermore, it is versatile and suitable for a wide array of vaccines, including inactivated, live attenuated, and protein-based formulations, making it a preferred route for various immunizations. This adaptability extends to all age groups, from infants to the elderly, facilitating comprehensive vaccination programs.

Breakup by Diseases:

Cancer

Infectious Diseases

Others

Infectious diseases hold the biggest share in the market

A detailed breakup and analysis of the market based on the diseases has also been provided in the report. This includes cancer, infectious diseases, and others. According to the report, infectious diseases accounted for the largest market share.

Vaccine adjuvants play a crucial role in the development of effective vaccines against infectious diseases. They stimulate and enhance the immune response to the antigens present in the vaccine. This means that smaller amounts of antigen can be used, reducing the cost of vaccine production and the potential for side effects. Vaccine adjuvants can help prolong the immune response, ensuring that the body continues to produce antibodies and memory cells for an extended period. This can lead to longer-lasting protection against infectious agents. Moreover, vaccine adjuvants can be tailored to elicit specific types of immune responses. Furthermore, they can help overcome immunosenescence by boosting the immune response in older individuals.

Breakup by Application:

Research

Commercial

Research holds the maximum share in the market

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes research and commercial. According to the report, research accounted for the largest market share.

Vaccine adjuvants are critical components in the field of vaccine research, playing a pivotal role in enhancing the effectiveness and safety of vaccines. These substances are added to vaccine formulations to boost the immune response, ultimately leading to better protection against infectious diseases. Adjuvants are particularly valuable in the development of vaccines against pathogens that are challenging to target using traditional vaccine approaches, such as viruses with rapidly mutating surface proteins or weakly immunogenic components. They are indispensable tools in vaccine research, serving to enhance immune responses, reduce antigen doses, and fine-tune the specificity of the immune system's reaction. Furthermore, scientists are investigating novel adjuvant formulations and delivery methods to maximize their effectiveness while minimizing potential side effects.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest vaccine adjuvants market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share due to increasing improvements in the healthcare sector to provide quality treatment to patients. Besides this, the increasing focus on the development of various novel vaccines, therapeutics, and medications for the treatment of rare diseases is propelling the growth of the market. Apart from this, increasing improvements in the fields of biotechnology and immunology to enable the development of adjuvants with improved safety profiles and enhanced efficacy are supporting the growth of the market.

Asia Pacific is estimated to expand further in this domain due to the rising prevalence of numerous infectious diseases caused by novel viruses. Additionally, the increasing conduction of public awareness campaigns and educational efforts to promote the benefits of vaccination is bolstering the growth of the market.

Competitive Landscape:

Key market players are developing innovative and more effective adjuvants by exploring new adjuvant formulations, delivery mechanisms, and combinations with vaccines to enhance their efficacy and safety. They are also forming strategic partnerships and collaborations with vaccine manufacturers, biotech firms, and research institutions for sharing expertise and resources and accessing new markets. Top companies are expanding their product portfolios by developing adjuvants that can be used in various types of vaccines, including those for infectious diseases, cancer, and autoimmune disorders. They are also focusing on ensuring that their adjuvants meet the necessary regulatory requirements and safety standards. Leading companies are expanding their presence in emerging markets, where the demand for vaccines and vaccine adjuvants is growing. They are also establishing manufacturing facilities, distribution networks, and partnerships with local organizations.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Adjuvance Tecchnologies Inc.

Adjuvatis

Agenus Inc.

Brenntag SE

Chemtrade Logistics Inc.

CSL Limited

Croda International Plc

Invivogen

Novavax Inc.

OZ Biosciences

Virometix AG

Recent Developments:

In January 2022, Adjuvance Tecchnologies Inc. announced the issuance of a U.S. patent covering semi-synthetic saponin adjuvants that exhibits improved adjuvant activity and reduced toxicity by the United States Patent and Trademark Office (USPTO).

In September 2021, Agenus Inc. announced the launch of its subsidiary, SaponiQx, which will drive innovation in novel adjuvant discovery and vaccine production.

In June 2023, Novavax Inc. announced the approval of the R21/Matrix-M™ malaria vaccine containing its Matrix-M, a saponin-based adjuvant by Agence Nationale de la Regulation Pharmaceutique (ANRP). Burkina Faso for use in children.

Key Questions Answered in This Report

  • 1. What was the size of the global vaccine adjuvants market in 2022?
  • 2. What is the expected growth rate of the global vaccine adjuvants market during 2023-2028?
  • 3. What are the key factors driving the global vaccine adjuvants market?
  • 4. What has been the impact of COVID-19 on the global vaccine adjuvants market?
  • 5. What is the breakup of the global vaccine adjuvants market based on the product type?
  • 6. What is the breakup of the global vaccine adjuvants market based on route of administration?
  • 7. What is the breakup of the global vaccine adjuvants market based on the diseases?
  • 8. What is the breakup of the global vaccine adjuvants market based on the application?
  • 9. What are the key regions in the global vaccine adjuvants market?
  • 10. Who are the key players/companies in the global vaccine adjuvants market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Vaccine Adjuvants Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Adjuvant Emulsions
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Pathogen Components
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Particulate Adjuvants
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Combination Adjuvants
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intramuscular
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Intranasal
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Subcutaneous
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Intradermal
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Diseases

  • 8.1 Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Infectious Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Research
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Commercial
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Adjuvance Tecchnologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Adjuvatis
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Agenus Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Brenntag SE
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Chemtrade Logistics Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 CSL Limited
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Croda International Plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Invivogen
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Novavax Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 OZ Biosciences
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Virometix AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Vaccine Adjuvants Market: Major Drivers and Challenges
  • Figure 2: Global: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Vaccine Adjuvants Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Vaccine Adjuvants Market: Breakup by Route of Administration (in %), 2022
  • Figure 6: Global: Vaccine Adjuvants Market: Breakup by Diseases (in %), 2022
  • Figure 7: Global: Vaccine Adjuvants Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Vaccine Adjuvants Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Vaccine Adjuvants (Adjuvant Emulsions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Vaccine Adjuvants (Adjuvant Emulsions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Vaccine Adjuvants (Pathogen Components) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Vaccine Adjuvants (Pathogen Components) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Vaccine Adjuvants (Particulate Adjuvants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Vaccine Adjuvants (Particulate Adjuvants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Vaccine Adjuvants (Combination Adjuvants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Vaccine Adjuvants (Combination Adjuvants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Vaccine Adjuvants (Other Product Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Vaccine Adjuvants (Other Product Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Vaccine Adjuvants (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Vaccine Adjuvants (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Vaccine Adjuvants (Intramuscular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Vaccine Adjuvants (Intramuscular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Vaccine Adjuvants (Intranasal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Vaccine Adjuvants (Intranasal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Vaccine Adjuvants (Subcutaneous) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Vaccine Adjuvants (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Vaccine Adjuvants (Intradermal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Vaccine Adjuvants (Intradermal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Vaccine Adjuvants (Other Routes of Administration) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Vaccine Adjuvants (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Vaccine Adjuvants (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Vaccine Adjuvants (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Vaccine Adjuvants (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Vaccine Adjuvants (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Vaccine Adjuvants (Other Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Vaccine Adjuvants (Other Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Vaccine Adjuvants (Research) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Vaccine Adjuvants (Research) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Vaccine Adjuvants (Commercial) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Vaccine Adjuvants (Commercial) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: North America: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: North America: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: United States: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: United States: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Canada: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Canada: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Asia-Pacific: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Asia-Pacific: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: China: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: China: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Japan: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Japan: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: India: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: India: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: South Korea: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: South Korea: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Australia: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Australia: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Indonesia: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Indonesia: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Europe: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Europe: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Germany: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Germany: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: France: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: France: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: United Kingdom: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: United Kingdom: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Italy: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Italy: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Spain: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Spain: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Russia: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Russia: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Latin America: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Latin America: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Brazil: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Brazil: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Mexico: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Mexico: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Others: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Others: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Middle East and Africa: Vaccine Adjuvants Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Middle East and Africa: Vaccine Adjuvants Market: Breakup by Country (in %), 2022
  • Figure 89: Middle East and Africa: Vaccine Adjuvants Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Global: Vaccine Adjuvants Industry: SWOT Analysis
  • Figure 91: Global: Vaccine Adjuvants Industry: Value Chain Analysis
  • Figure 92: Global: Vaccine Adjuvants Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Vaccine Adjuvants Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Vaccine Adjuvants Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Vaccine Adjuvants Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 4: Global: Vaccine Adjuvants Market Forecast: Breakup by Diseases (in Million US$), 2023-2028
  • Table 5: Global: Vaccine Adjuvants Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Vaccine Adjuvants Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Vaccine Adjuvants Market: Competitive Structure
  • Table 8: Global: Vaccine Adjuvants Market: Key Players